Dr. Sandeep  Rajput
My Social Links

Dr. Sandeep Rajput

Post-doctoral Fellow
Washington University School of Medicine, USA


Highest Degree
Ph.D. in Molecular Biochemistry from Southern Illinois University, USA

Share this Profile

Biography

Dr. Sandeep Rajput is currently working as Postdoctoral Research Associate at Washington University School of Medicine, USA. He obtained his Ph.D. in Molecular Biochemistry from Southern Illinois University, USA. His main area of interest focuses on Pharmacology and Toxicology, Biomedical Sciences, and Molecular Sciences. His area of expertise includes Cancer Biology, Chemoresistance, Signaling Pathways, Anticancer Drug Therapy, Drug Mechanisms, Targeted therapy, Mechanism of Action, Stem Cells, microRNA, and Protein Biochemistry. He has 8 publications in journals as author/co-author.

Area of Interest:

Pharmacology and Toxicology
100%
Cancer Biology
62%
Chemoresistance
90%
Signaling Pathways
75%
Stem Cells
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Khera, N. and S. Rajput, 2017. Therapeutic potential of small molecule inhibitors. J. Cell. Biochem., 118: 959-961.
    CrossRef  |  Direct Link  |  
  2. Rajput, S., N. Khera, Z. Guo, J. Hogg and C. Ma, 2016. Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer. Oncotarget, 7: 56864-56875.
    CrossRef  |  Direct Link  |  
  3. Rajput, S. and C.X. Ma, 2016. Beyond genomics: biologic insights from the CPTAC proteogenomic analysis of breast cancer. Transl. Cancer Res., 5: S713-S715.
    CrossRef  |  Direct Link  |  
  4. Volk-Draper, L., K. Hall, C. Griggs, S. Rajput, P. Kohio, D. DeNardo and S. Ran, 2014. Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner. Cancer Res., 74: 5421-5434.
    CrossRef  |  Direct Link  |  
  5. Rajput, S., L.D. Volk-Draper and S. Ran, 2013. TLR4 is a novel determinant of the response to paclitaxel in breast cancer. Mol. Cancer Ther., 12: 1676-1687.
    CrossRef  |  PubMed  |  
  6. Luo, D., Y. Bu, J. Ma, S. Rajput, Y. He and G. Cai, 2013. Heat shock protein 90-alpha mediates Akr1b10 secretion through secretory lysosomes. J. Biol. Chem. 10.1074/jbc.M113.514877.
    CrossRef  |  Direct Link  |  
  7. Volk-Draper, L.D., S. Rajput, K.L. Hall, A. Wilber and S. Rana, 2012. Novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapy. Neoplasia, 14: 926-942.
    CrossRef  |  Direct Link  |  
  8. Luo, D.X., D.J. Tong, S. Rajput, C. Wang, D.F. Liao, D. Cao and E. Maser, 2012. Targeting acetyl-CoA carboxylases: Small molecular inhibitors and their therapeutic potential. Recent Pat Anticancer Drug Discov., 7: 168-184.
    PubMed  |  
  9. Rajput, S. and A. Wilber, 2010. Role of inflammation in cancer initiation, cancer progression and cancer metastasis. Front. Biosci., 2: 176-183.
  10. Joshi, A., S. Rajput and D. Cao, 2010. Mouse aldo-keto reductases: AKR1B8 is an ortholog of human AKR1B10. Biol. Chem., 391: 1371-1378.
  11. Wang, C., S. Rajput, K. Watabe, D.F. Liao and D. Cao, 2009. Acetyl-CoA carboxylase-a as a novel target for cancer therapy. Front. Biosci., 2: 515-526.
    CrossRef  |  Direct Link  |